RA
CVS icon

Ruggaard & Associates’s CVS Health CVS Stock Holding History

Ruggaard & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,965
Closed -$396K – 117
2024
Q1 		$396K Hold
4,965
– – 0.19% 72
2023
Q4 		$392K Sell
4,965
-2,165
-30% -$154K 0.21% 70
2023
Q3 		$498K Sell
7,130
-1,244
-15% -$88.1K 0.3% 57
2023
Q2 		$579K Sell
8,374
-60
-0.7% -$4.27K 0.34% 45
2023
Q1 		$627K Buy
+8,434
New +$707K 0.39% 30

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ruggaard & Associates's CVS Position: Q2 2024 in Review

Ruggaard & Associates sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,965 shares — an estimated $396K sold.

Ruggaard & Associates first reported a position in CVS in Q1 2023 and held it in 5 quarters. The position peaked at $627K in Q1 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Ruggaard & Associates reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Ruggaard & Associates sold 4,965 CVS Health shares in Q2 2024, an estimated $396K.
  • Ruggaard & Associates first reported a position in CVS Health in Q1 2023 and held it in 5 quarters.
  • Ruggaard & Associates's CVS Health position peaked at $627K in Q1 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Ruggaard & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.